PCM
BSX icon

Polymer Capital Management’s Boston Scientific BSX Stock Holding History

Polymer Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$592K Sell
13,869
-129
-0.9% -$7K 0.08% 306
2026
Q1 		$878K Buy
13,998
+6,944
+98% +$556K 0.09% 242
2025
Q4 		$673K Sell
7,054
-291
-4% -$28.5K 0.07% 398
2025
Q3 		$717K Buy
+7,345
New +$761K 0.08% 313

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Polymer Capital Management's BSX Position: Q2 2026 in Review

Polymer Capital Management reduced its Boston Scientific (BSX) stake by 0.92% in Q2 2026, selling an estimated $7K and leaving 13,869 shares worth $592K. The position accounts for 0.08% of the portfolio, ranked #306.

Polymer Capital Management first reported a position in BSX in Q3 2025 and has held it in 4 quarters since. The position peaked at $878K in Q1 2026. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Polymer Capital Management held 13,869 shares of Boston Scientific worth $592K as of Q2 2026.
  • Polymer Capital Management sold 129 Boston Scientific shares in Q2 2026, an estimated $7K.
  • Boston Scientific made up 0.08% of Polymer Capital Management's portfolio in Q2 2026, its #306 holding.
  • Polymer Capital Management first reported a position in Boston Scientific in Q3 2025 and has held it in 4 quarters since.
  • Polymer Capital Management's Boston Scientific position peaked at $878K in Q1 2026.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Polymer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.